Bezzi, Manuela

Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death: evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. [electronic resource] - The Journal of biological chemistry Oct 2003 - 43603-14 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0021-9258

10.1074/jbc.M308114200 doi


Adenoviridae--genetics
Angiogenesis Inhibitors--pharmacology
Annexin A5--metabolism
Apoptosis
Cell Adhesion--drug effects
Cell Death
Cell Membrane--metabolism
Cell Movement--drug effects
Cell Survival--drug effects
Cells, Cultured
Clodronic Acid--pharmacology
Coloring Agents--pharmacology
Diphosphonates--pharmacology
Electroporation
Endothelial Cells--drug effects
Endothelium, Vascular--cytology
Enzyme Activation
Flow Cytometry
Focal Adhesion Kinase 1
Focal Adhesion Protein-Tyrosine Kinases
Humans
Imidazoles--pharmacology
Integrin alpha5beta1--metabolism
Integrin alphaVbeta3--metabolism
Microscopy, Fluorescence
Phosphorylation
Protein Serine-Threonine Kinases
Protein-Tyrosine Kinases--metabolism
Proto-Oncogene Proteins--metabolism
Proto-Oncogene Proteins c-akt
Tumor Necrosis Factor-alpha--metabolism
Umbilical Veins--cytology
Zoledronic Acid